
12-Digit NDC transition
Assess. Prepare. Implement.
Prepare for the FDA’s NDC transformation with Nubinno’s expert support at every stage.
Is your organization ready for the 12-Digit NDC transition?
The FDA’s transition to the 12-digit NDC format requires more than system updates. It demands a clear understanding of how NDC data impacts your products, processes, systems, partners, and compliance activities.
Organizations that start assessing their readiness now will have greater flexibility, lower implementation risk, and a smoother path to compliance.
Nubinno helps pharmaceutical companies assess readiness, identify risks, and build structured transition plans tailored to their organization.
How can Nubinno support your transition?
-
- NDC impact assessment
Identify systems, processes, interfaces, and business functions affected by the transition.
-
- NDC readiness review
Evaluate your organization’s preparedness and prioritize next steps.
-
- Master data assessment
Review NDC, GTIN, and product data structures to identify potential risks.
-
- Serialization & GTIN analysis
Assess dependencies between NDC, GTIN generation, serialization, and reporting processes.
-
- ERP & system readiness evaluation
Identify field-length limitations, hardcoded logic, and integration risks.
-
- Validation & compliance planning
Define testing, validation, and documentation requirements for impacted systems.
-
- Trading partner readiness assessment
Evaluate potential risks across CMOs, wholesalers, solution providers, and supply chain partners.
-
- Implementation roadmap development
Build a practical transition plan with priorities, milestones, and resource requirements.
-
- Risk & business continuity assessment
Identify operational risks and prepare mitigation strategies before implementation begins.
-
- Expert advisory & project support
Access experienced serialization consultants throughout your NDC transition journey.
NDC Resources
Discover Nubinno ‘s expert insights on the 12-Digit NDC transition
Explore NDC insights

